In this way, NPs could be used to deliver DNA vectors to ectopically express healthy variants of genes related to transcytosis in the BECs of AD patients who carry genetic variants with potential risk for this disease, such as PICALM, BIN1, CD2AP, and RIN3. The gene discussed is CD2AP; the disease is Alzheimer disease.